REGULATION OF PLASMINOGEN RECEPTOR EXPRESSION ON HUMAN MONOCYTES AND MONOCYTOID CELL-LINES

被引:68
作者
FELEZ, J
MILES, LA
PLESCIA, J
PLOW, EF
机构
关键词
D O I
10.1083/jcb.111.4.1673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The capacity of human monocytoid cell lines and peripheral blood monocytes to modulate their expession of plasminogen receptors has been assessed. After PMA stimulation, THP-1 or U937 monocytoid cells were separated into adherent and nonadherent populations. Plasminogen bound to adherent cells with similar capacity and affinity as to non-stimulated cells. In contrast, the nonadherent cells bound plasminogen with 5-17-fold higher capacity (without a change in affinity). This increase was selective as urokinase bound with similar affinity and caapacity to the adherent and nonadherent populations. Upregulation of plasminogen receptors on the nonadherent monocytoid cells was rapid, detectable within 30 min, and reversible, adhesion of the nonadherent cells resulted in a sixfold decrease in plasminogen binding within 90 min. The increase in plasminogen binding to the nonadherent cells was associated with a marked increase in their capacity to generate plasmin activity from cell-bound plasminogen. PMA stimulation of human peripheral blood monocytes increased their expression of plasminogen receptors by two- to fourfold. This increase was observed in both adherent and nonadherent monocytes. Freshly isolated monocytes maximally bound 5.0 x 105 plasminogen molecules per cell, whereas monocytes cultured for 18 h or more maximally bound 1.7 x 107 molecules per cell, a 30-fold difference in receptor number. These results indicate that both monocytes and monocytoid cell lines can rapidly and markedly regulate their expression of plasminogen binding sites. As enhanced plasminogen binding is correlated with an increased capacity to generate plasmin, an enzyme with broad substrate recognition, modulation of plasminogen receptors may have profound functional consequences.
引用
收藏
页码:1673 / 1683
页数:11
相关论文
共 62 条
[1]   CRYPTIC UROKINASE BINDING-SITES ON HUMAN FORESKIN FIBROBLASTS [J].
BAJPAI, A ;
BAKER, JB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 133 (02) :475-482
[2]  
BARNATHAN ES, 1988, J BIOL CHEM, V263, P7792
[3]   BINDING OF TISSUE PLASMINOGEN-ACTIVATOR TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
BEEBE, DP .
THROMBOSIS RESEARCH, 1987, 46 (02) :241-254
[4]   ANTI-MAC-1 SELECTIVELY INHIBITS THE MOUSE AND HUMAN TYPE 3 COMPLEMENT RECEPTOR [J].
BELLER, DI ;
SPRINGER, TA ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) :1000-1009
[5]   RECEPTORS FOR COLD-INSOLUBLE GLOBULIN (PLASMA FIBRONECTIN) ON HUMAN-MONOCYTES [J].
BEVILACQUA, MP ;
AMRANI, D ;
MOSESSON, MW ;
BIANCO, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (01) :42-60
[6]  
BLASI F, 1988, Fibrinolysis, V2, P73, DOI 10.1016/0268-9499(88)90370-0
[7]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[8]   RECEPTOR FOR PLASMIN ON HUMAN CARCINOMA-CELLS [J].
BURTIN, P ;
FONDANECHE, MC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (10) :762-765
[9]   LIMITED PROTEOLYSIS OF TUMOR-CELLS INCREASES THEIR PLASMIN-BINDING ABILITY [J].
CAMACHO, M ;
FONDANECHE, MC ;
BURTIN, P .
FEBS LETTERS, 1989, 245 (1-2) :21-24
[10]   CHARACTERIZATION OF A MACROPHAGE-DERIVED PLASMINOGEN-ACTIVATOR INHIBITOR - SIMILARITIES WITH PLACENTAL UROKINASE INHIBITOR [J].
CHAPMAN, HA ;
STONE, OL .
BIOCHEMICAL JOURNAL, 1985, 230 (01) :109-116